In vitro, the co-administrationof GOx-LGP and TRAIL-LGP induced robust apoptosis in both murine (HCA-1)and human (Hep3B) HCC cells, as evidenced by significantly increasedAnnexin V/PI staining compared to either monotherapy (Figure A). The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.